Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.60% | 163.54 | 0.7% | $1305.95m | |
| LLY | Eli Lilly & Co. | -1.93% | 323.65 | 1.1% | $1056.02m | |
| ABBV | AbbVie, Inc. | -5.84% | 134.38 | 1.9% | $793.06m | |
| PFE | Pfizer Inc. | -0.75% | 43.83 | 0.9% | $778.51m | |
| BMY | Bristol-Myers Squibb Co. | -0.82% | 71.12 | 1.0% | $763.08m | |
| MRK | Merck & Co., Inc. | -0.52% | 86.19 | 0.7% | $687.90m | |
| AZN | AstraZeneca Plc | -0.13% | 54.84 | 1.0% | $411.81m | |
| NVS | Novartis AG | -0.73% | 76.01 | 0.2% | $216.26m | |
| GSK | GSK Plc | 0.31% | 29.45 | 0.3% | $214.53m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -4.41% | 200.16 | 8.2% | $210.64m | |
| GBT | Global Blood Therapeutics, Inc. | 0.04% | 68.10 | 5.4% | $190.73m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.21% | 151.22 | 0.0% | $178.64m | |
| IDXX | IDEXX Laboratories, Inc. | -1.81% | 325.80 | 3.9% | $175.84m | |
| HZNP | Horizon Therapeutics Plc | -1.28% | 61.89 | 5.4% | $160.55m | |
| NVO | Novo Nordisk A/S | -0.74% | 99.65 | 0.1% | $140.44m |
Company Profile
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.